Breast Cancer
Conditions
Brief summary
To study if Healing Touch is effective during chemotherapy treatment for breast cancer
Detailed description
To study the effectiveness of Healing Touch provided during chemotherapy infusions on the experience of women undergoing treatment for breast cancer. Healing Touch (HT) is a gentle, non-invasive form of energy-balancing work that promotes relaxation and can help manage the side effects of chemotherapy.
Interventions
PROCEDUREHealing Touch
every other week (during their infusion)
OTHERStandard care
Adriamycin, cyclophosphamide, and paclitaxel administered as standard of care
PROCEDUREguided relaxation
Sponsors
Stanford University
Study design
Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
- Stage I or II breast cancer * Post-operative * Concurrent enrollment on a treatment protocol of 8 weeks of adriamycin + cyclophosphamide given every other week followed by 8 weeks of paclitaxel given every other week * ECOG Performance Status: 0 to 2 * Speak and read English
Exclusion criteria
- Previous chemotherapy exposure \- Concomitant energy-work interventions (HT, Reiki, QiGong, acupuncture).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FACT-B summary score | Baseline, 6 wks, 14 wks |
Secondary
| Measure | Time frame |
|---|---|
| Domain scores for FACT-B; BSI-18; FACIT-Fatigue; nausea measured on a Likert scale | Baseline, 6 wks, 14 wks |
Countries
United States
Outcome results
None listed